Infectious Diseases in Obstetrics and Gynecology

Infectious Diseases in Obstetrics and Gynecology / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 768380 |

Wouter J. Meijer, Annemarie M. J. Wensing, Hein W. Bruinse, Peter G. J. Nikkels, "High Rate of Chronic Villitis in Placentas of Pregnancies Complicated by Influenza A/H1N1 Infection", Infectious Diseases in Obstetrics and Gynecology, vol. 2014, Article ID 768380, 5 pages, 2014.

High Rate of Chronic Villitis in Placentas of Pregnancies Complicated by Influenza A/H1N1 Infection

Academic Editor: Flor Munoz
Received06 Nov 2013
Revised30 Dec 2013
Accepted02 Jan 2014
Published16 Feb 2014


Introduction. Pandemic influenza A/H1N1 infection during pregnancy has a negative impact on several aspects of pregnancy outcome. As yet, no elucidating mechanism has been revealed for these effects. We investigated whether placentas of pregnancies complicated by 2009 influenza A/H1N1 infection demonstrated an increased rate of chronic villitis and whether this villitis was caused by influenza virus. Methods. We performed a cohort study on 145 pregnant outpatients during the 2009-2010 influenza A H1N1 pandemic. The placentas of patients with influenza infection were examined for histologic signs of chronic villitis. In case of villitis, polymerase chain reaction (PCR) on influenza virus was performed on placental tissue. Results. 29 patients had influenza infection. Placentas of 15 of these patients were collected and examined. In 7 cases (47%) chronic villitis was detected. Placental weight and birth weight of the neonates did not differ between cases with and without chronic villitis. In all cases PCR was negative for influenza. Conclusion. In our series, chronic villitis was present in a high proportion of placentas of pregnancies complicated by 2009 influenza A/H1N1 infection. We could not demonstrate the presence of influenza virus in placental tissue.

1. Introduction

Pregnant women are at increased risk of 2009 influenza A/H1N1 infection and its complications [13]. The viral infection does not only cause significant maternal morbidity, but also have a negative impact on pregnancy outcome in women hospitalized because of the infection. Preterm birth rates and stillbirth have been reported to be more prevalent in these women compared to noninfected women [47]. As well, it is reported that up to 25% of neonates born from mothers that recovered from severe influenza virus infection during pregnancy were small for gestational age [8]. It is unclear by which mechanism influenza virus infection causes these negative effects on pregnancy outcome. We hypothesized that chronic villitis, known to be associated with both intrauterine growth restriction and stillbirth and considered to be of viral origin in a considerable percentage of cases, may be responsible for these effects. We investigated whether chronic villitis was more prevalent in placentas of neonates whose mother had been affected by influenza infection during pregnancy compared to placentas of a cohort of uncomplicated pregnancies. We also investigated whether influenza could be demonstrated in placentas with chronic villitis.

2. Materials and Methods

We conducted a cohort study to investigate the effects of maternal influenza A/H1N1 infection on the course of pregnancy. The study protocol was approved by the local medical ethical review board and the clinical investigation was conducted according to the principles expressed in the Declaration of Helsinki. Data were collected from October 2009 until June 2010. All outpatients were asked to participate. Demographic data were collected from the charts of those who participated. Patients could be enrolled at any moment during pregnancy. At enrollment, patients filled out a questionnaire on vaccination against influenza virus, influenza like symptoms during the past six months, and, if this was the case, use of anti-influenza antiviral drugs. Influenza like symptoms were defined as fever ≥38,0°C, malaise, and cough eventually combined with myalgia. Patients were prospectively followed up. In case of influenza like symptoms, PCR on influenza on a swab taken from nose and pharynx was done. Data on pregnancy outcome were collected from the medical records.

Clinical cases of influenza virus infection were defined as influenza like symptoms: fever ≥38,0°C, malaise, and cough eventually combined with myalgia during the 2009 influenza pandemic in absence of a confirmatory PCR. Confirmed cases were defined as patients with a positive PCR on influenza. Placentas of women with influenza virus infection were examined histologically. If signs of chronic villitis were present, a PCR on placental tissue with chronic villitis was done.

DNA extraction of the paraffin embedded tissue was performed by conventional xylene deparaffinization, two xylene washes 60 minutes RT, two 96% ethanol washes, and one acetone wash followed by protease K digestion (18 hours, 56°C).

PCR was performed as follows. Nucleic acids were extracted using the total nucleic acid (for swabs) or DNA II tissue protocol (for placental tissue) with the MagNA pure LC nucleic acid isolation system (Roche Diagnostics, Basel, Switzerland). Each sample was eluted in 200 L buffer, which was sufficient for all real time PCR analyses. cDNA was synthesized by using MultiScribe reverse transcriptase (RT) and random hexamers (both from Applied Biosystems, Foster City, CA, USA). Each 200 L reaction mixture contained 80 L of eluted RNA, 20 L of 10X RT buffer, 5.5 mmol/L MgCl2, 500 mol/L of each deoxynucleoside triphosphate, 2.5 mol/L random hexamer, and 0.4 U of RNase inhibitor per microlitre (all from Applied Biosystems). After incubation for 10 minutes at 25°C, RT was carried out for 30 minutes at 48°C, followed by RT inactivation for 5 minutes at 95°C. The PCR consisted of a final concentration of 1X Universal Master Mix (Applied Biosystems), 900 nM of each primer, 150 nM of the influenza A probe, and 2 L of target cDNA and was made up to a volume of 25 L with nuclease free water (Promega Corp., Madison, USA). The real time quantitative PCR amplifications were measured in real time mode using the ABI7500 (Applied Biosystems).

Histologic examination of placentas was done by an experienced pathologist. The placentas were weighted without membranes and umbilical cord, and the weight was classified according to gestational age percentiles from Pinar et al. [9]. Routine hematoxylin and eosin stained slides from a minimum of 2 umbilical cord sections (at the fetal and placental side), a membrane roll, one sample from the umbilical cord insertion, and two slides of normal placental parenchyma, including decidua and chorionic plate, and additional slides from macroscopical abnormalities were reviewed. Chorioamnionitis was diagnosed based on the presence of polymorphonuclear cells (neutrophilic granulocytes) in the chorionic plate or the extraplacental membranes. Diagnosis of funisitis was based on the presence of neutrophilic granulocytes in the wall of the umbilical vein and/or arteries and Wharton’s jelly. Chronic villitis was diagnosed as an infiltrate of lymphocytes and macrophages in the placental villi. In addition to the presence of chorioamnionitis, funisitis, or villitis, the severity of inflammation was graded mild, moderate, or severe, according to the staging and grading system of Redline [10] with slight modifications as previously published [11] and presented in Table 1.


0No inflammationNo inflammationNo inflammation
0.5Sporadic PMN in chorionic plate/membranes
1Frequent PMN in chorionic plate/membranesInflammation present in the wall of 1 vessel (vein)1 section with 1 focus of chronic inflammation of >5 villi
2Invasion of chorionic plate, large infiltrate in chorionic plate/membranesInflammation present in the wall of 2 vessels (vein and artery)2-3 sections with each having 1 focus of chronic inflammation of >5 villi
3Same as 2, including microabscesses in chorionic plateInflammation present in the wall of 3 vessels (vein and 2 arteries)3 sections with each having >2 foci of chronic inflammation of >5 villi

PMNs: polymorphonuclear cells.

2.1. Polymorphonuclear Cells (PMNs)

Placental parenchymal infarction was defined as an area of necrotic villi surrounded by an area of ischaemia with increased hyperchromasia of trophoblast and increased syncytial knotting. Fetal thrombotic lesions were scored as at least 5 avascular fibrotic villi without inflammation or mineralization or if adherent thrombi in stem vessels were present. An increase of nucleated red blood cells in the fetal circulation is the consequence of either anaemia or hypoxia and was scored when nucleated red blood cells were present in more than two capillaries in a random 10x field.

We compared the results of the histologic examination of the placentas with those of a historic cohort that was published before [11]. This cohort consisted of placentas derived from uncomplicated pregnancies with spontaneous onset of labor and vaginal delivery. The placentas in this cohort were examined in the same way and by the same laboratory and pathologist as the placentas collected in this study.

3. Results

In total 145 patients participated in our study. Data were incomplete in nine patients. Of the participants, 29 (20%) were clinical cases of influenza virus infection, of which 6 were tested by PCR. All PCRs tested positive. All 29 pregnant women gave live birth and both mothers and children were discharged in good health. We were able to collect 15 out of 29 placentas.

Of these 15, 10 were clinical cases and 5 were PCR proven influenza cases. Baseline characteristics and pregnancy outcome of the 15 patients are presented in Table 2.

Number of patients ( )15
Age (y)
 Mean (SD)33 (5,8)
 Nulliparous ( (%))5 (33)
 Parous ( (%))10 (67)
 None ( (%))11 (73)
 Asthma ( (%))1 (7)
 Hypertension ( (%))1 (7)
 Other systemic diseases* ( (%))2 (13)
Mode of delivery
 Vaginal delivery ( (%))10 (67)
 Cesarean section ( (%))5 (33)
Gestational age
 Mean (days (SD))280 (10)
  Preterm <37 weeks ( (%))1 (7)
  Preterm <34 weeks ( (%))0 (0)

One patient had rheumatoid arthritis and one patient had polycystic ovary syndrome.

Gestational age at onset of symptoms varied from 2 to 32 weeks with a median of 21 weeks of gestation. There were 5 patients with infection in the first, 8 in the second, and 2 in the third trimester of pregnancy. None of the patients had to be admitted to the hospital. Three of the patients were treated with oseltamivir. Other treatments included amoxicillin (±clavulanic acid) in 4 patients, paracetamol in 1 patient, and no treatment in 4 patients. In all but one patient, symptoms subsided within 10 days.

In 7 out of 15 placentas (47%) chronic villitis was present. Results are shown in Table 3. All 7 PCRs run on placental tissue were negative.

Villitis of any grade ( , (%))Villitis of grade 1 ( )Villitis of grade 2 ( )Villitis of grade 3 ( )

PCR confirmed cases ( )3 (60)300
Clinical cases ( )4 (40)220
Total ( )7 (47)520
Historic cohort* ( )65 (24)46163

Historic cohort consists of placentas of women with uncomplicated pregnancy and vaginal delivery, as described in Section 2 [11].

When comparing characteristic between those patients whose placentas showed villitis to those whose placentas did not, there were no differences in average duration from infection to delivery (153 days (SD 64 days) and 140 days (SD 67 days) for cases with resp. without chronic villitis). There were also no differences in placental weight, birth weight of the neonates and number of neonates that were small for gestational age. In the placentas with chronic villitis 3 out of 7 placentas were below 10th percentile for placental weight according to gestational age, while all placentas without chronic villitis were of normal weight. Results are shown in Table 4. There were no differences in chorioamnionitis, funisitis, infarction, or thrombosis (results not shown).

Placental weight
(grams, mean (SD))
Placental weight < p10
( , (%))
Birth weight
(grams, mean (SD))
Birth weight < p10
( , (%))

No villitis ( )487 (93)0 (0)3317 (510)1 (14)
Chronic villitis ( )447 (57)3 (38)3176 (480)0 (0)

Placental weight for gestational age was classified according to Pinar et al. [9].
Birth weight for gestational age was classified according to the new Dutch reference curves for birth weight by gestational age [12].

4. Discussion

In our study sample, chronic villitis was present in 47% of placentas. This appears to be considerably higher than the 24% in our historic cohort and even more different from the 5–15% reported by Redline [10]. Comparing the 47% in our cohort with the 24% in our historic cohort yields an absolute difference of 23% with a 95% confidence interval for difference of −3 to 49%. Interestingly, the placentas of all three women treated with oseltamivir demonstrated chronic villitis (all grade 1). However, the relatively small number of placentas that we were able to study makes it hard to draw any firm conclusions on these numbers.

The etiology of chronic villitis is not fully elucidated yet. Some cases can be attributed to infections with microorganisms like cytomegalovirus or Treponema pallidum. A large proportion of cases of chronic villitis however were classified as villitis of unknown etiology (VUE) and may reflect a noninfectious immune response. Which proportion of chronic villitis has to be attributed to viral infections and which proportion has to be classified as VUE is still a matter of debate [10, 13]. In some cases these conditions can be distinguished by using certain characteristics on routine histological examination [10]. However, it is also reported that 41% of lesions originally classified as VUE appear to have a viral origin when examined by electron microscopy [14]. Regardless of its etiology, recent reports including a meta-analysis have confirmed the association of VUE with intrauterine growth restriction and, to a lesser extent, with pregnancy loss [15, 16].

In our series we found five grade 1 and two grade 2 lesions. The small size of our study sample limits the ability to detect differences in pregnancy outcomes between cases with and without chronic villitis. We found no significant difference in birth weight of neonates and there were also no significant differences between placental weight and number of placentas with placental weight < p10, although the latter almost reached statistical difference ().

We were not able to demonstrate the presence of 2009 influenza A/H1N1 in placental tissue with histological signs of chronic villitis. Several reasons might exist for this result. First, chronic villitis may be unrelated to influenza infection. Second, the pregnant women in our cohort were relatively mildly affected by the virus. Pregnant women who are more severely affected and have viraemia may be more prone to placental infection by influenza [17]. Nevertheless, for seasonal influenza A H1N1 placental infection and vertical transmission have been reported even when maternal symptoms were mild [18]. Third, the virus might also have been cleared from placental tissue since the time between infection and delivery was relatively long in our cohort. Fourth, we may not have selected the appropriate patients and/or placentas to examine, since 10 out of 15 of our cases were clinical cases without a confirmative PCR. However, given that all patients tested by PCR on pharyngeal swab had a proven infection, a large proportion of patients that were not tested but had similar symptoms during the influenza pandemic will probably have had influenza infection as well. Therefore, we expect a large proportion of clinical cases to be actual influenza infections. Finally, placental tissue was embedded in paraffin. This may have decreased the sensitivity of the PCRs, since both natural degradation of RNA and the fixation and paraffin-embedding procedure may interfere with the transcription and amplification of RNA [19]. On the other hand, we selected those pieces of placental tissue that showed chronic villitis, hypothesizing that we would have optimal chances of finding evidence of placental infection by influenza if present.

Our findings are in line with results from Turkey [20]. In a series of seven placentas derived from pregnancies complicated by proven pandemic influenza A H1N1 infection, Kanmaz et al. performed PCR on random pieces of placental tissue not related to any histologic abnormalities. Like us, they did not find evidence of viral replication in placental tissue.

Still, influenza infection may be related to chronic villitis. The increased prevalence of chronic villitis of unknown etiology in women with autoimmune diseases and in ovum donor pregnancies suggests that it results from a disturbance of normal pregnancy tolerance, which is predominantly regulated by several types of T cells [16]. The immunogenic activity of these cells, however, is influenced by cytokines that are known to be increased in influenza virus infection [21, 22]. We therefore hypothesize that the burst of inflammatory cytokines accompanying influenza virus infection may produce lesions of chronic villitis. Given the limitations of our study and the limited literature on this subject further studies are needed to affirm or deny this hypothesis.

5. Conclusions

In our small series, we found a high proportion of placentas with chronic villitis in women infected with 2009 influenza A/H1N1 during pregnancy. We could not demonstrate that chronic villitis was caused by direct infection of the placenta with influenza virus. Our results underline the need for further investigation of whether the immune response triggered by influenza virus infection is responsible for the increased rates of serious adverse events that occur in pregnancies complicated by influenza virus infection.

Conflict of Interests

The authors declare that there is no conflict of interests concerning the publication of this paper.


The authors would like to thank Edwin Vries, Annemiek van der Eijk, Caroline Murk, and Guus Rimmelzwaan for their assistance.


  1. M. E. Falagas, P. K. Koletsi, E. Baskouta, P. I. Rafailidis, G. Dimopoulos, and D. E. Karageorgopoulos, “Pandemic A(H1N1) 2009 influenza: review of the Southern Hemisphere experience,” Epidemiology and Infection, vol. 139, no. 1, pp. 27–40, 2011. View at: Publisher Site | Google Scholar
  2. M. E. Falagas, N. V. Cholevas, A. M. Kapaskelis, E. K. Vouloumanou, A. Michalopoulos, and P. I. Rafailidis, “Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 29, no. 11, pp. 1327–1347, 2010. View at: Publisher Site | Google Scholar
  3. M. D. Van Kerkhove, K. A. Vandemaele, V. Shinde et al., “Risk factors for severe outcomes following 2009 influenza A, (H1N1) infection: a global pooled analysis,” PLOS Medicine, vol. 8, no. 7, Article ID e1001053, 2011. View at: Google Scholar
  4. L. Yates, M. Pierce, S. Stephens et al., “Influenza A/HINIv in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant,” Health Technology Assessment, vol. 14, no. 34, pp. 109–182, 2010. View at: Publisher Site | Google Scholar
  5. A. Nakai, H. Minakami, N. Unno et al., “Characteristics of pregnant Japanese women who required hospitalization for treatment of pandemic (H1N1) 2009—low mortality rate may be due to early antiviral use,” Journal of Infection, vol. 62, no. 3, pp. 232–233, 2011. View at: Publisher Site | Google Scholar
  6. M. Pierce, J. J. Kurinczuk, P. Spark, P. Brocklehurst, and M. Knight, “H1N1v influenza in pregnancy in the UK,” Archives of Disease in Childhood. Fetal and Neonatal Edition, vol. 95, article Fa6, 2010. View at: Publisher Site | Google Scholar
  7. S. E. Håberg, L. Trogstad, N. Gunnes et al., “Risk of fetal death after pandemic influenza virus infection or vaccination,” The New England Journal of Medicine, vol. 368, no. 4, pp. 333–340, 2013. View at: Google Scholar
  8. Centers for Disease Control and Prevention (CDC), “Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)—United States, April 2009-August 2010,” Morbidity and Mortality Weekly Report, vol. 60, no. 35, pp. 1193–1196, 2011. View at: Google Scholar
  9. H. Pinar, C. J. Sung, C. E. Oyer, and D. B. Singer, “Reference values for singleton and twin placental weights,” Pediatric Pathology and Laboratory Medicine, vol. 16, no. 6, pp. 901–907, 1996. View at: Google Scholar
  10. R. W. Redline, “Villitis of unknown etiology: noninfectious chronic villitis in the placenta,” Human Pathology, vol. 38, no. 10, pp. 1439–1446, 2007. View at: Publisher Site | Google Scholar
  11. M. L. Houben, P. G. J. Nikkels, G. M. van Bleek et al., “The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study,” PLoS ONE, vol. 4, no. 8, Article ID e6572, 2009. View at: Publisher Site | Google Scholar
  12. G. H. A. Visser, P. H. C. Eilers, P. M. Elferink-Stinkens, H. M. W. M. Merkus, and J. M. Wit, “New Dutch reference curves for birthweight by gestational age,” Early Human Development, vol. 85, no. 12, pp. 737–744, 2009. View at: Publisher Site | Google Scholar
  13. L. G. Greer, M. S. Ziadie, B. M. Casey, B. B. Rogers, D. D. McIntire, and K. J. Leveno, “An immunologic basis for placental insufficiency in fetal growth restriction,” American Journal of Perinatology, vol. 29, pp. 533–538, 2012. View at: Publisher Site | Google Scholar
  14. A. O’Malley and J. E. Gillan, “The incidence of viral infection causing villitis,” Placenta, vol. 26, article 38, 2005. View at: Google Scholar
  15. H. Derricott, R. L. Jones, and A. E. Heazell, “Investigating the association of villitis of unknown etiology with stillbirth and fetal growth restriction—a systematic review,” Placenta, vol. 34, pp. 856–862, 2013. View at: Google Scholar
  16. J. A. Tamblyn, D. M. Lissauer, R. Powell, P. Cox, and M. D. Kilby, “The immunological basis of villitis of unknown etiology—review,” Placenta, vol. 34, no. 10, pp. 846–855, 2013. View at: Google Scholar
  17. H. Tse, K. K. W. To, X. Wen et al., “Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection,” PLoS ONE, vol. 6, no. 9, Article ID e22534, 2011. View at: Publisher Site | Google Scholar
  18. R. W. Lieberman, N. Bagdasarian, D. Thomas, and C. van de Ven, “Seasonal influenza A (H1N1) infection in early pregnancy and second trimester fetal demise,” Emerging Infectious Diseases, vol. 17, no. 1, pp. 107–109, 2011. View at: Publisher Site | Google Scholar
  19. M. D. McKinney, S. J. Moon, D. A. Kulesh, T. Larsen, and R. J. Schoepp, “Detection of viral RNA from paraffin-embedded tissues after prolonged formalin fixation,” Journal of Clinical Virology, vol. 44, no. 1, pp. 39–42, 2009. View at: Publisher Site | Google Scholar
  20. H. Gozde Kanmaz, O. Erdeve, S. Suna Oǧz et al., “Placental transmission of novel pandemic influenza a virus,” Fetal and Pediatric Pathology, vol. 30, no. 5, pp. 280–285, 2011. View at: Publisher Site | Google Scholar
  21. S. Saito, A. Nakashima, T. Shima, and M. Ito, “Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy,” American Journal of Reproductive Immunology, vol. 63, no. 6, pp. 601–610, 2010. View at: Publisher Site | Google Scholar
  22. A. Bradley-Stewart, L. Jolly, W. Adamson et al., “Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09,” Journal of Clinical Virology, vol. 58, pp. 100–107, 2013. View at: Google Scholar

Copyright © 2014 Wouter J. Meijer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.